To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Supplementation with Boswellia serrata extract versus placebo for knee osteoarthritis treatment

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
June 2019

Supplementation with Boswellia serrata extract versus placebo for knee osteoarthritis treatment

Vol: 8| Issue: 6| Number:20| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee

Phytother Res. 2019 May;33(5):1457-1468. doi: 10.1002/ptr.6338

Contributing Authors:
M Majeed S Majeed NK Narayanan K Nagabhushanam

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

48 patients with knee osteoarthritis were randomized to daily oral supplementation with either Boswellia serrata extract or placebo. Patients were followed over 4 months of treatment for outcome related to pain and function. After 4 months, results demonstrated significantly greater improvement in the BSE group for the Western Ontario and McMaster Universities Osteoarthritis Index, visual analog p...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue